The
global Injection Pens Market is expected to reach USD
67.9 billion by 2025, according to a new report by Grand View Research, Inc.,
registering a 9.4% CAGR during the forecast period. High demand for these
devices for management of various chronic as well as acute diseases and
increasing awareness in developing regions are key factors expected to drive
the market.
Injectable
pens have witnessed significant success in improving patient convenience during
management of chronic disease, a process that might include administering
intermittent injections. These devices are more convenient and affordable than
other delivery systems. Ongoing studies on the same to assess their
applications in management of other diseases, including but not limited to
Hepatitis C and cancer, is expected to ensure swift market growth through 2025.
Related Press
Release@ Injection Pen Market Report
Injection Pen Market Report Highlights
- Rising
incidence of diseases such as diabetes and arthritis is primarily boosting
market growth
- Increase in
government healthcare expenditure and availability of favorable healthcare
insurance policies in developed as well as developing countries is driving
the market
- By product,
reusable injectable pens are the largest and fastest growing segment owing
to the advantages associated with them such as cost effectiveness and
patient convenience. Commercially available reusable injectable pens
mainly include Novopen, Luxura, Berlipen, AllStar, NovoRapid, basalgar,
Bydureon, Epipen and Genotropin
- By dosage,
variable dosage is the fastest growing segment. Some of the customizable
variable pens are UnoPen, ServoPen and Ypsopen by Ypsomed, Madie by SHL
Group, and Evo pen by Copernicus
- North
America dominates the market, followed by Europe. Technological advancements
and increase in incidence of osteoporosis, arthritis, and anaphylaxis are
factors that can be attributable to its largest market share
- Asia Pacific
is expected to be the fastest growing region over the forecast period.
Better accessibility to healthcare, coupled with constantly increasing
healthcare expenditure in the region, is fueling market growth
- China is one
of the most lucrative markets with tremendous growth opportunities for
global as well as local players. This is owing to favorable factors such
as availability of labor and raw materials at significantly lower prices
as compared to other regions
- Key players
in the market include Owen Mumford Ltd.; GlaxoSmithKline plc; Eli Lilly
and Company; Mylan N.V.; AstraZeneca; Novo Nordisk; Sanofi; and Sandoz
Inc.
Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/5362/rfc
Injection Pen Market Segmentation
Grand
View Research has segmented the global injection pens market on the basis of
product, dosage, application, and region:
Injection Pens Product Outlook (Revenue, USD Billion,
2014 - 2025)
- Disposable
- Reusable
Injection Pens Dosage Outlook (Revenue, USD Billion, 2014
- 2025)
- Fixed
- Variable
Injection Pens Application Outlook (Revenue, USD Billion,
2014 - 2025)
- Diabetes
- Insulin
- Non-insulin
- Anaphylaxis
- Osteoporosis
- Growth
hormone deficiency
- Arthritis
- Others
Injection Pens Regional Outlook (Revenue, USD Billion,
2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Greece
- Denmark
- Spain
- Norway
- Belgium
- Austria
- Asia Pacific
- Japan
- China
- India
- Thailand
- Australia
- Singapore
- Malaysia
- Sri Lanka
- Bangladesh
- South Korea
- Latin
America
- Brazil
- Mexico
- Argentina
- MEA
- UAE
- Saudi
Arabia
- South
Africa
- Qatar
- Kuwait
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment